Dexamethasone Ophthalmic

Contraindicated

Dexamethasone Ophthalmic Desmopressin DDAVP Increased risk of severe hyponatremia Details Dexamethasone Ophthalmic Ensitrelvir Increased CYP3A substrates exposure and an increased risk of CYP3A substrates-related adverse effects Details Dexamethasone Ophthalmic Mifepristone Korlym Reduced miFEPRIStone exposure, reduced efficacy of miFEPRIStone, increased dexAMETHasone exposure, an increased risk of autoimmune... Details Dexamethasone Ophthalmic Praziquantel Biltricide Significantly decreased praziquantel plasma concentrations Details Dexamethasone Ophthalmic Ranolazine Aspruzyo Reduced ranolazine exposure Details Dexamethasone Ophthalmic Rilpivirine Edurant Reduced rilpivirine exposure, reduced efficacy of rilpivirine and an increased risk of loss of virologic response Details Dexamethasone Ophthalmic Zoliflodacin Reduced zoliflodacin exposure and reduced efficacy of zoliflodacin Details

Major

Dexamethasone Ophthalmic Abametapir Increased exposure of CYP3A4 substrate Details Dexamethasone Ophthalmic Aceclofenac Increased risk of gastrointestinal ulcer or bleeding Details Dexamethasone Ophthalmic Acemetacin Increased risk of gastrointestinal ulcer or bleeding Details Dexamethasone Ophthalmic Aldesleukin Proleukin Reduced antitumor effectiveness Details Dexamethasone Ophthalmic Alfentanil Reduced ALfentanil exposure, reduced efficacy of ALfentanil and an increased risk of a withdrawal syndrome Details Dexamethasone Ophthalmic Amiodarone Nexterone Reduced amiodarone exposure and reduced efficacy of amiodarone Details Dexamethasone Ophthalmic Amlodipine Amvaz® Reduced amLODIPine exposure Details Dexamethasone Ophthalmic Amtolmetin Guacil Increased risk of gastrointestinal ulcer or bleeding Details Dexamethasone Ophthalmic Apalutamide Erleada Reduced dexAMETHasone exposure Details Dexamethasone Ophthalmic Artemether Reduced artemether/lumefantrine exposure, reduced efficacy of artemether/lumefantrine, loss of antimalarial efficacy, reduced CYP3... Details Dexamethasone Ophthalmic Aspirin Acuprin® An increased risk of salicylism subsequent to withdrawal of corticosteroids Details Dexamethasone Ophthalmic Atazanavir Reyataz Reduced atazanavir exposure, reduced efficacy of atazanavir, increased dexAMETHasone exposure and increased risk of dexAMETHasone-... Details Dexamethasone Ophthalmic Atogepant Qulipta Reduced atogepant exposure Details Dexamethasone Ophthalmic Avacopan Tavneos Increased CYP3A4 substrate exposure Details Dexamethasone Ophthalmic Balofloxacin An increased risk of tendon rupture Details Dexamethasone Ophthalmic Bemiparin Increased risk of bleeding Details Dexamethasone Ophthalmic Benzhydrocodone Reduced HYDROcodone exposure and reduced efficacy HYDROcodone Details Dexamethasone Ophthalmic Besifloxacin An increased risk of tendon rupture Details Dexamethasone Ophthalmic Boceprevir Reduced boceprevir plasma concentrations and increased dexamethasone plasma concentrations Details Dexamethasone Ophthalmic Bromfenac Bromsite Increased risk of gastrointestinal ulcer or bleeding Details Dexamethasone Ophthalmic Bufexamac Increased risk of gastrointestinal ulcer or bleeding Details Dexamethasone Ophthalmic Buprenorphine Belbuca Reduced buprenorphine exposure and reduced efficacy of buprenorphine Details Dexamethasone Ophthalmic Bupropion Aplenzin Lowering of the seizure threshold Details Dexamethasone Ophthalmic Carbamazepine Carbatrol Reduced dexAMETHasone exposure and reduced carBAMazepine exposure Details Dexamethasone Ophthalmic Cariprazine Vraylar Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Dexamethasone Ophthalmic Celecoxib Celebrex Increased risk of gastrointestinal ulcer or bleeding Details Dexamethasone Ophthalmic Ceritinib Zykadia Increased CYP3A substrate exposure Details Dexamethasone Ophthalmic Cholestyramine Prevalite Decreased dexamethasone concentration Details Dexamethasone Ophthalmic Choline Salicylate Increased risk of gastrointestinal ulcer or bleeding Details Dexamethasone Ophthalmic Ciprofloxacin An increased risk of tendon rupture Details Dexamethasone Ophthalmic Clarithromycin Biaxin Reduced CYP3A substrate exposure and increased dexAMETHasone exposure Details Dexamethasone Ophthalmic Clonixin Increased risk of gastrointestinal ulcer or bleeding Details Dexamethasone Ophthalmic Cobicistat Tybost Reduced cobicistat exposure and increased dexAMETHasone exposure Details